Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Falk Hertwig

Showing results (11-20 of 33) with videos related to

Pageof 4
Sort By:
Plos Computational Biology|November 4, 2021
Neuroblastoma signalling models unveil combination therapies targeting feedback-mediated resistanceMathurin Dorel, Bertram Klinger, Tommaso Mari, et al.
Cell Reports|July 12, 2016
Regulation of Nuclear Hormone Receptors by MYCN-Driven miRNAs Impacts Neural Differentiation and Survival in Neuroblastoma PatientsDiogo Ribeiro, Marcus D R Klarqvist, Ulrica K Westermark, et al.
Journal of Clinical Medicine|October 26, 2024
Targeting KDM1A in Neuroblastoma with NCL-1 Induces a Less Aggressive Phenotype and Suppresses AngiogenesisAnnika Sprüssel, Takayoshi Suzuki, Naoki Miyata, et al.
Nature Genetics|November 16, 2021
Chromothripsis followed by circular recombination drives oncogene amplification in human cancerCarolina Rosswog, Christoph Bartenhagen, Anne Welte, et al.
Cell Genomics|October 23, 2023
Mutational topography reflects clinical neuroblastoma heterogeneityElias Rodriguez-Fos, Mercè Planas-Fèlix, Martin Burkert, et al.
JCO Precision Oncology|February 1, 2022
Telomerase Is a Prognostic Marker of Poor Outcome and a Therapeutic Target in NeuroblastomaAndrea Roderwieser, Frederik Sand, Esther Walter, et al.
Oncotarget|March 2, 2018
The mutational landscape of <i>MYCN</i>, <i>Lin28b</i> and <i>ALK</i><sup></sup> driven murine neuroblastoma mimics human diseaseBram De Wilde, Anneleen Beckers, Sven Lindner, et al.
Cancers|February 13, 2026
YAP1 Enhances Mesenchymal-Type Gene Expression in Human Adrenergic-Type Neuroblastoma CellsMarius Ludwig, Kerstin Ahrens, Annika Winkler, et al.
Cancer Cell|December 18, 2014
The risk-associated long noncoding RNA NBAT-1 controls neuroblastoma progression by regulating cell proliferation and neuronal differentiationGaurav Kumar Pandey, Sanhita Mitra, Santhilal Subhash, et al.
Journal of Personalized Medicine|August 27, 2021
Neuroblastoma Risk Assessment and Treatment Stratification with Hybrid Capture-Based Panel SequencingAnnabell Szymansky, Louisa-Marie Kruetzfeldt, Lukas C Heukamp, et al.
Pageof 4

Showing results (11-20 of 33) with videos related to

Sort By:
Pageof 4
Plos Computational Biology|November 4, 2021
Neuroblastoma signalling models unveil combination therapies targeting feedback-mediated resistanceMathurin Dorel, Bertram Klinger, Tommaso Mari, et al.
Cell Reports|July 12, 2016
Regulation of Nuclear Hormone Receptors by MYCN-Driven miRNAs Impacts Neural Differentiation and Survival in Neuroblastoma PatientsDiogo Ribeiro, Marcus D R Klarqvist, Ulrica K Westermark, et al.
Journal of Clinical Medicine|October 26, 2024
Targeting KDM1A in Neuroblastoma with NCL-1 Induces a Less Aggressive Phenotype and Suppresses AngiogenesisAnnika Sprüssel, Takayoshi Suzuki, Naoki Miyata, et al.
Nature Genetics|November 16, 2021
Chromothripsis followed by circular recombination drives oncogene amplification in human cancerCarolina Rosswog, Christoph Bartenhagen, Anne Welte, et al.
Cell Genomics|October 23, 2023
Mutational topography reflects clinical neuroblastoma heterogeneityElias Rodriguez-Fos, Mercè Planas-Fèlix, Martin Burkert, et al.
JCO Precision Oncology|February 1, 2022
Telomerase Is a Prognostic Marker of Poor Outcome and a Therapeutic Target in NeuroblastomaAndrea Roderwieser, Frederik Sand, Esther Walter, et al.
Oncotarget|March 2, 2018
The mutational landscape of <i>MYCN</i>, <i>Lin28b</i> and <i>ALK</i><sup></sup> driven murine neuroblastoma mimics human diseaseBram De Wilde, Anneleen Beckers, Sven Lindner, et al.
Cancers|February 13, 2026
YAP1 Enhances Mesenchymal-Type Gene Expression in Human Adrenergic-Type Neuroblastoma CellsMarius Ludwig, Kerstin Ahrens, Annika Winkler, et al.
Cancer Cell|December 18, 2014
The risk-associated long noncoding RNA NBAT-1 controls neuroblastoma progression by regulating cell proliferation and neuronal differentiationGaurav Kumar Pandey, Sanhita Mitra, Santhilal Subhash, et al.
Journal of Personalized Medicine|August 27, 2021
Neuroblastoma Risk Assessment and Treatment Stratification with Hybrid Capture-Based Panel SequencingAnnabell Szymansky, Louisa-Marie Kruetzfeldt, Lukas C Heukamp, et al.
Pageof 4